Mediwound ( (MDWD) ) just unveiled an announcement.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
In a recent announcement, MediWound Ltd. reported that key members of its Board of Directors and the CEO have purchased a total of 18,462 ordinary shares in the open market. These acquisitions, conducted between December 9 and December 13, 2024, reflect the leadership’s confidence in the company’s future prospects and adherence to insider trading policies. This move is likely to bolster stakeholder confidence and might enhance the company’s standing in the investment community.
More about Mediwound
MediWound Ltd. operates in the medical industry, specializing in the development and commercialization of innovative therapies for burn and wound care. The company focuses on providing advanced treatment solutions to improve healing in patients with severe injuries.
YTD Price Performance: 70.01%
Average Trading Volume: 45,201
Technical Sentiment Consensus Rating: Hold
Current Market Cap: $186.5M
See more data about MDWD stock on TipRanks’ Stock Analysis page.
